• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症的发病率、发病机制及管理:概述

Incidence, pathogenesis, and management of sepsis: an overview.

作者信息

Kleinpell Ruth M, Graves Brian T, Ackerman Michael H

机构信息

Rush University College of Nursing, Chicago, IL 60612, USA.

出版信息

AACN Adv Crit Care. 2006 Oct-Dec;17(4):385-93. doi: 10.4037/15597768-2006-4005.

DOI:10.4037/15597768-2006-4005
PMID:17091040
Abstract

Sepsis is a complex condition that occurs as a result of the systemic manifestation of infection. It is associated with high morbidity and mortality risks for critically ill patients. Assessment and monitoring aimed at early recognition and treatment, on the basis of evidence-based guidelines, are advocated for optimizing outcomes for patients with severe sepsis. Awareness of the risk factors, clinical signs and symptoms, pathophysiology, and updates in the management of sepsis can enhance the nursing care for patients with severe sepsis to promote best practices for sepsis care in the intensive care unit. This article reviews the incidence and pathophysiology of sepsis, highlighting updates in treatment and implications for nursing care.

摘要

脓毒症是一种由于感染的全身表现而发生的复杂病症。它与重症患者的高发病率和高死亡率风险相关。提倡基于循证指南进行旨在早期识别和治疗的评估与监测,以优化重症脓毒症患者的治疗结果。了解脓毒症的风险因素、临床体征和症状、病理生理学以及脓毒症管理方面的最新进展,可加强对重症脓毒症患者的护理,以促进重症监护病房脓毒症护理的最佳实践。本文综述了脓毒症的发病率和病理生理学,重点介绍了治疗方面的最新进展及其对护理的影响。

相似文献

1
Incidence, pathogenesis, and management of sepsis: an overview.脓毒症的发病率、发病机制及管理:概述
AACN Adv Crit Care. 2006 Oct-Dec;17(4):385-93. doi: 10.4037/15597768-2006-4005.
2
Targeting sepsis as a performance improvement metric: role of the nurse.将脓毒症作为绩效改进指标:护士的作用。
AACN Adv Crit Care. 2014 Apr-Jun;25(2):179-86. doi: 10.1097/NCI.0000000000000015.
3
Sepsis: An Update on Current Practices in Diagnosis and Management.脓毒症:诊断与管理的当前实践更新。
Am J Med Sci. 2018 Sep;356(3):277-286. doi: 10.1016/j.amjms.2018.06.012. Epub 2018 Jun 18.
4
Critical care in the emergency department: severe sepsis and septic shock.急诊科的重症监护:严重脓毒症和脓毒性休克
Emerg Med J. 2006 Sep;23(9):713-7. doi: 10.1136/emj.2005.029934.
5
Evidence-based updates to the 2016 Surviving Sepsis Guidelines and clinical implications.《2016年拯救脓毒症指南》基于证据的更新及临床意义。
Nurse Pract. 2019 Feb;44(2):26-33. doi: 10.1097/01.NPR.0000552679.69145.80.
6
Sepsis: an overview of the signs, symptoms, diagnosis, treatment and pathophysiology.脓毒症:体征、症状、诊断、治疗及病理生理学概述
Emerg Nurse. 2019 Sep 2;27(5):32-41. doi: 10.7748/en.2019.e1926.
7
Sepsis: pathophysiology and clinical management.脓毒症:病理生理学与临床管理。
BMJ. 2016 May 23;353:i1585. doi: 10.1136/bmj.i1585.
8
An updated review of sepsis for the anesthesiologist.麻醉医生关于脓毒症的最新综述。
Semin Cardiothorac Vasc Anesth. 2013 Dec;17(4):262-8. doi: 10.1177/1089253213504141. Epub 2013 Sep 6.
9
Insights into severe sepsis in older patients: from epidemiology to evidence-based management.老年患者严重脓毒症的见解:从流行病学到循证管理
Clin Infect Dis. 2005 Mar 1;40(5):719-27. doi: 10.1086/427876. Epub 2005 Jan 28.
10
Implications of the new international sepsis guidelines for nursing care.新国际脓毒症指南对护理的影响。
Am J Crit Care. 2013 May;22(3):212-22. doi: 10.4037/ajcc2013158.

引用本文的文献

1
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation.CB2和GPR55受体作为全身免疫失调的治疗靶点
Front Pharmacol. 2016 Aug 22;7:264. doi: 10.3389/fphar.2016.00264. eCollection 2016.
2
Ethyl pyruvate protects against sepsis by regulating energy metabolism.丙酮酸乙酯通过调节能量代谢来预防败血症。
Ther Clin Risk Manag. 2016 Feb 23;12:287-94. doi: 10.2147/TCRM.S97989. eCollection 2016.
3
MicroRNA-147b regulates vascular endothelial barrier function by targeting ADAM15 expression.微小RNA-147b通过靶向ADAM15表达来调节血管内皮屏障功能。
PLoS One. 2014 Oct 15;9(10):e110286. doi: 10.1371/journal.pone.0110286. eCollection 2014.
4
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis.脓毒症中实验性大麻素2受体介导的免疫调节
Mediators Inflamm. 2014;2014:978678. doi: 10.1155/2014/978678. Epub 2014 Apr 3.
5
The effect of pomegranate extract on survival and peritoneal bacterial load in cecal ligation and perforation model of sepsis in rats.石榴提取物对大鼠盲肠结扎穿孔脓毒症模型生存率及腹腔细菌载量的影响
Int J Prev Med. 2014 Jan;5(1):104-9.
6
Eritoran: the evidence of its therapeutic potential in sepsis.埃瑞托单抗:其在脓毒症中治疗潜力的证据
Core Evid. 2008 Feb 29;2(3):199-207.
7
Based on the four segments and treatment by syndrome differentiation to lower the mortality of sepsis.基于四环节及辨证论治降低脓毒症死亡率。
Chin J Integr Med. 2009 Feb;15(1):16-8. doi: 10.1007/s11655-009-0016-x. Epub 2009 Mar 7.